Palo Alto, United States
Inceptive, founded in 2021, positions itself at the forefront of the Biotechnology and Life Sciences industries with its innovative approach to crafting "Biological Software." Their mission, encapsulated by their slogan, "Learn Life's Languages," involves the creation of synthetic molecules capable of executing complex functions within biological systems. This groundbreaking approach aims to make previously unreachable medicines and biotechnologies accessible on a broader scale.
Supported by an antedisciplinary team, Inceptive is a magnet for scientists, ML researchers, engineers, and entrepreneurs eager to revolutionize how we understand and engage with biological processes. The recent $100.00M Series A investment on 07 September 2023, backed by prominent investors such as Obvious Ventures, Andreessen Horowitz/a16z, Nvidia, and Section 32, underscores its strong potential. Headquartered in the United States, the company is strategically poised for significant impact and growth in the evolving landscape of biotechnological innovation.
